\BOOKMARK [0][-]{section*.1}{An Agent-Based Model of COVID-19 Diffusion to Plan and Evaluate Intervention Policies}{}% 1
\BOOKMARK [0][-]{section*.1}{Gianpiero Pescarmona, Pietro Terna, Alberto Acquadro, Paolo Pescarmona, Giuseppe Russo, Emilio Sulis, and Stefano Terna}{}% 2
\BOOKMARK [1][-]{section.0.1}{A quick introduction to epidemic modeling}{section*.1}% 3
\BOOKMARK [2][-]{subsection.0.1.1}{Why model? Why agents? Why another model?}{section.0.1}% 4
\BOOKMARK [2][-]{subsection.0.1.2}{Our model}{section.0.1}% 5
\BOOKMARK [1][-]{section.0.2}{How S.I.s.a.R. works}{section*.1}% 6
\BOOKMARK [2][-]{subsection.0.2.1}{A day of the simulation}{section.0.2}% 7
\BOOKMARK [2][-]{subsection.0.2.2}{Conditional actions}{section.0.2}% 8
\BOOKMARK [2][-]{subsection.0.2.3}{Parameters}{section.0.2}% 9
\BOOKMARK [2][-]{subsection.0.2.4}{Agents' interaction}{section.0.2}% 10
\BOOKMARK [2][-]{subsection.0.2.5}{Model calendar}{section.0.2}% 11
\BOOKMARK [1][-]{section.0.3}{The visualization of the sequences of contagions in simulated epidemics}{section*.1}% 12
\BOOKMARK [2][-]{subsection.0.3.1}{Contagion sequences}{section.0.3}% 13
\BOOKMARK [2][-]{subsection.0.3.2}{A few sequences suggesting a policy via counterfactual limitations}{section.0.3}% 14
\BOOKMARK [1][-]{section.0.4}{Simulation repetition and emerging key results}{section*.1}% 15
\BOOKMARK [1][-]{section.0.5}{Genetic Algorithms: the tools and the goal}{section*.1}% 16
\BOOKMARK [1][-]{section.0.6}{The sequence of the contagions in a simulated epidemic}{section*.1}% 17
\BOOKMARK [1][-]{section.0.7}{Applying Genetic Algorithms \(GA\)}{section*.1}% 18
\BOOKMARK [2][-]{subsection.0.7.1}{Population groups}{section.0.7}% 19
\BOOKMARK [2][-]{subsection.0.7.2}{Vaccination quantities}{section.0.7}% 20
\BOOKMARK [1][-]{section.0.8}{Vaccination experiments}{section*.1}% 21
\BOOKMARK [1][-]{section.0.9}{Experiment I, with few infected agents at the vaccination starting point}{section*.1}% 22
\BOOKMARK [2][-]{subsection.0.9.1}{Planned vaccination campaigns in Experiment I}{section.0.9}% 23
\BOOKMARK [2][-]{subsection.0.9.2}{Experiment I, following GAs suggestions}{section.0.9}% 24
\BOOKMARK [2][-]{subsection.0.9.3}{A very short comment on Experiment I}{section.0.9}% 25
\BOOKMARK [1][-]{section.0.10}{Experiment synopsis}{section*.1}% 26
\BOOKMARK [1][-]{section.0.11}{To do}{section*.1}% 27
\BOOKMARK [1][-]{section.0.12}{Cost-benefit analysis of the of interventions}{section*.1}% 28
\BOOKMARK [1][-]{section.0.13}{Summarizing}{section*.1}% 29
\BOOKMARK [1][-]{section*.2}{Acknowledgements}{section*.1}% 30
\BOOKMARK [1][-]{section.0.14}{Appendix: Analyzing examples of contagion sequences}{section*.1}% 31
\BOOKMARK [2][-]{subsection.0.14.1}{How to analyze the figures of this section}{section.0.14}% 32
\BOOKMARK [2][-]{subsection.0.14.2}{Epidemics without containment measures}{section.0.14}% 33
\BOOKMARK [2][-]{subsection.0.14.3}{Cases with containment measures}{section.0.14}% 34
\BOOKMARK [2][-]{subsection.0.14.4}{Short running epidemic, with containment measures}{section.0.14}% 35
\BOOKMARK [1][-]{section.0.15}{Appendix: batches of 1,000 simulated experiments generating data for policy proposals}{section*.1}% 36
\BOOKMARK [2][-]{subsection.0.15.1}{Epidemics without containment measures}{section.0.15}% 37
\BOOKMARK [2][-]{subsection.0.15.2}{Epidemics with basic non-pharmaceutical containment measures, no school in September 2020}{section.0.15}% 38
\BOOKMARK [2][-]{subsection.0.15.3}{Epidemics with immediate stop of fragile workers, non-pharmaceutical containment measures, no school in September 2020}{section.0.15}% 39
\BOOKMARK [2][-]{subsection.0.15.4}{Epidemics with absolute isolation of nursing homes, non-pharmaceutical containment measures, no school in September 2020}{section.0.15}% 40
\BOOKMARK [2][-]{subsection.0.15.5}{Epidemics stopping fragile people, non-pharmaceutical containment measures, no school in September 2020}{section.0.15}% 41
\BOOKMARK [2][-]{subsection.0.15.6}{Epidemics excluding fragility of any type, non-pharmaceutical containment measures, no school in September 2020}{section.0.15}% 42
\BOOKMARK [2][-]{subsection.0.15.7}{Epidemics excluding fragility of any type, non-pharmaceutical containment measures, factories open, no school in September 2020}{section.0.15}% 43
\BOOKMARK [2][-]{subsection.0.15.8}{Epidemics excluding fragility of any type, non-pharmaceutical containment measures, factories open, schools open in September 2020}{section.0.15}% 44
\BOOKMARK [1][-]{section.0.16}{Appendix: How the visualization of contagion sequences works}{section*.1}% 45
\BOOKMARK [2][-]{subsection.0.16.1}{The data}{section.0.16}% 46
\BOOKMARK [2][-]{subsection.0.16.2}{The plot}{section.0.16}% 47
\BOOKMARK [2][-]{subsection.0.16.3}{The colors}{section.0.16}% 48
\BOOKMARK [1][-]{section.0.17}{Appendix: The calendar}{section*.1}% 49
\BOOKMARK [1][-]{section.0.18}{Appendix: Memo}{section*.1}% 50
\BOOKMARK [1][-]{section*.3}{References}{section*.1}% 51
\BOOKMARK [1][-]{section*.3}{References}{section*.1}% 52
